life sciences

Latest news and analysis on life sciences

Innate Immunotherapeutics - An MS drug candidate where the patients are saying good things

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

A biotech that's been misunderstood

MSB
Livewire Exclusive
Livewire Markets

PolyNovo - CSIRO-developed technology hits the big time

PNV
Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Bionomics' new drug that the world is likely to pay attention to

BNO
Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Viralytics - The Steel City's valuable contribution to defeating cancer

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Mayne Pharma - Emerging world leader in generic drugs

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Nanosonics makes it into the black as our latest billion dollar Life Sciences success story

NAN
Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Boom times for AFT Pharmaceuticals

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Monoclonal antibodies are a >US$70bn drug class. This Aussie company is set to revolutionise that market

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research

Clinuvel - Proof that Australian companies can do world-class drug development

Stuart Roberts
Stuart Roberts
Pitt Street Research and NDF Research
41-50 of 67
The 10th annual Livewire Live 2026

One room. One day. The minds that move markets.

22 September 2026 Art Gallery of NSW, Sydney

Register Now